85 related articles for article (PubMed ID: 27890566)
1. Management of interruptions to fractionated radiotherapy treatments: Four and a half years of experience.
de la Vega JM; Ríos B; Del Río JT; Guerrero R; Castillo I; Guirado D
Phys Med; 2016 Dec; 32(12):1551-1558. PubMed ID: 27890566
[TBL] [Abstract][Full Text] [Related]
2. Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.
Maciá I Garau M; Solé Monné J; Cambra Serés MJ; Monfà Binefa C; Peraire Llopis M
Clin Transl Oncol; 2009 May; 11(5):302-11. PubMed ID: 19451063
[TBL] [Abstract][Full Text] [Related]
3. The management of interruptions to radiotherapy in head and neck cancer: an audit of the effectiveness of national guidelines.
James ND; Williams MV; Summers ET; Jones K; Cottier B;
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):599-605. PubMed ID: 18555671
[TBL] [Abstract][Full Text] [Related]
4. A national audit of radiotherapy in head and neck cancer.
James ND; Robertson G; Squire CJ; Forbes H; Jones K; Cottier B;
Clin Oncol (R Coll Radiol); 2003 Apr; 15(2):41-6. PubMed ID: 12708709
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules.
Wyatt RM; Jones BJ; Dale RG
Br J Radiol; 2008 Jul; 81(967):549-63. PubMed ID: 18378526
[TBL] [Abstract][Full Text] [Related]
6. Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer.
Fesinmeyer MD; Mehta V; Blough D; Tock L; Ramsey SD
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):675-81. PubMed ID: 20133084
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
[TBL] [Abstract][Full Text] [Related]
8. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
Xiong W; Li J; Ma CM
Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
[TBL] [Abstract][Full Text] [Related]
9. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
[TBL] [Abstract][Full Text] [Related]
10. Radiobiological compensation for unintended treatment interruptions during palliative radiotherapy.
Jones B; Hopewell JW; Dale RG
Br J Radiol; 2007 Dec; 80(960):1006-10. PubMed ID: 18065646
[TBL] [Abstract][Full Text] [Related]
11. Completion of radiotherapy for local and regional head and neck cancer in medicare.
Fesinmeyer MD; Mehta V; Tock L; Blough D; McDermott C; Ramsey SD
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):860-7. PubMed ID: 19770417
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for head and neck cancer: latest developments and future perspectives.
Bernier J; Bentzen SM
Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
[TBL] [Abstract][Full Text] [Related]
13. Individual patients' data meta-analyses in head and neck cancer.
Bourhis J; Le Maître A; Baujat B; Audry H; Pignon JP; ; ;
Curr Opin Oncol; 2007 May; 19(3):188-94. PubMed ID: 17414635
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)].
Marchal C; Lapeyre M; Beckendorf V; Aletti P; Haslé E; Dubois JB; Maingon P; Bensadoun RJ; Le Prise E; Lartigau E; Carrie C; Dubray B; Marchesi V; Ailleres N; Naudy S; Marcie S; Manens JP; Mazurier J; Ginestet C; Chauvin F; Pommier P; Gerard JP; Carrere MO
Cancer Radiother; 2004 Nov; 8 Suppl 1():S121-7. PubMed ID: 15679257
[TBL] [Abstract][Full Text] [Related]
15. Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma.
Combs SE; Behnisch W; Kulozik AE; Huber PE; Debus J; Schulz-Ertner D
BMC Cancer; 2007 Sep; 7():177. PubMed ID: 17854490
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated radiation therapy for prostate cancer: The McGill University Health Center experience.
Barbosa Neto O; Souhami L; Faria S
Cancer Radiother; 2015 Oct; 19(6-7):431-6. PubMed ID: 26278988
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in radiotherapy for head and neck cancers.
Chou RH; Wilder RB; Wong MS; Forster KM
Ear Nose Throat J; 2001 Oct; 80(10):704-7, 711-4, 716 passim. PubMed ID: 11605568
[TBL] [Abstract][Full Text] [Related]
18. The impact of introducing intensity modulated radiotherapy into routine clinical practice.
Miles EA; Clark CH; Urbano MT; Bidmead M; Dearnaley DP; Harrington KJ; A'Hern R; Nutting CM
Radiother Oncol; 2005 Dec; 77(3):241-6. PubMed ID: 16298002
[TBL] [Abstract][Full Text] [Related]
19. The first implementation of IMRT technique for head & neck and prostate cancer patients in public sector in Greece: feasibility, treatment planning and dose delivery verification using the delta(4PT) Pre-Treatment volumetric quality assurance system.
Kouloulias V; Antypas C; Liakouli Z; Armpilia C; Zygogianni A; Floros I; Tolia M; Kokakis J; Kouvaris J
J BUON; 2015; 20(1):196-205. PubMed ID: 25778316
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
